§ Funding Round
Series C funding round for Pulmocide raising $52M in December 2022
Series C funding round for Pulmocide raising $52M in December 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Asahi Kasei Pharma | — | — |
Cystic Fibrosis Foundation | — | — |
| Organization | — | |
| Angel | sabine dandiguian | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SR One | — | — |
SV Health Investors | — | — |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$205.4M
Top Valuation
-
Pulmocide raised $52M in a Series C round.
The round was announced on 12/01/22.
